Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
The most significant clinical data on retatrutide to date come from a Phase 2 randomised controlled trial published in the New England Journal of Medicine (2023), which evaluated the drug across multiple doses in adults with obesity
Lets break down what we know
Your clinician can consider switching from semaglutide to another GLP-1 receptor agonist, adjusting titration, or adding targeted medications like prokinetics
It offers a novel approach by mimicking the incretin hormones that are involved in appetite regulation and insulin secretion, making it a dual purpose treatment for those struggling with their weight
US$ 27.59
US$ 29.34
US$ 28.08
US$ 20.14
US$ 22.73
US$ 27.76
US$ 27.51
US$ 24.29
US$ 29.42
